Ilsung Pharm (003120) — Cash Flow Reinvestment Rate
Ilsung Pharm (003120) has a Cash Flow Reinvestment Rate of 0.56x as of June 2025, reinvesting ₩2.89 Billion (capex ₩395.62 Million plus investments ₩-2.50 Billion) from operating cash flow of ₩5.13 Billion. Explore Ilsung Pharm capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ilsung Pharm Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Ilsung Pharm across 9 annual periods. Also explore Ilsung Pharm (003120) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Ilsung Pharm (2013–2025)
Year-by-year capital reinvestment analysis for Ilsung Pharm. For live market cap and broader valuation context, see Ilsung Pharm market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.26x | ₩8.79 Billion | ₩3.88 Billion | ₩2.18 Billion | ▼ -59.9% |
| 2021 | 5.65x | ₩32.21 Billion | ₩5.70 Billion | ₩10.93 Billion | ▲ +25.1% |
| 2020 | 4.52x | ₩7.03 Billion | ₩1.56 Billion | ₩4.82 Billion | ▼ -11.7% |
| 2019 | 5.11x | ₩22.44 Billion | ₩4.39 Billion | ₩1.24 Billion | ▲ +540.5% |
| 2018 | 0.80x | ₩12.05 Billion | ₩15.09 Billion | ₩1.21 Billion | ▲ +96.7% |
| 2017 | 0.41x | ₩4.12 Billion | ₩10.16 Billion | ₩1.85 Billion | ▼ -58.5% |
| 2015 | 0.98x | ₩5.91 Billion | ₩6.04 Billion | ₩2.85 Billion | ▼ -37.6% |
| 2014 | 1.57x | ₩6.57 Billion | ₩4.19 Billion | ₩945.31 Million | ▲ +222.5% |
| 2013 | 0.49x | ₩2.46 Billion | ₩5.06 Billion | ₩1.13 Billion | — |